Linked e-resources
Details
Table of Contents
Intro; Contents; About the Authors; 1: Introduction to Herbal Medicine; 1.1 Some Basic Definitions; 1.2 History of Herbal Medicine; 1.3 Renaissance of Herbal Medicine; 1.4 Herbal Glossary; 2: Medicinal Herbs Used in Herbal Medicine for Neurological Disorders; 2.1 Albizia julibrissin Baker (Fabaceae); 2.2 Acorus gramineus Sol. Aiton (Acoraceae); 2.3 Acorus tatarinowii Schott (Acoraceae); 2.4 Amphilophium crucigerum (L.) L.G.Lohmann (Bignoniaceae); 2.5 Galphimia glauca Cav. (Malpighiaceae); 2.6 Hypoxis hemerocallidea Fisch. & C. A. Mey. (Hypoxidaceae)
2.7 Litsea glaucescens Kunth (Lauraceae)2.8 Leonurus sibiricus L. (Lamiaceae); 2.9 Melissa officinalis L. (Lamiaceae); 2.10 Nepeta cataria L. (Lamiaceae); 2.11 Nepeta hindostana (Roth) Haines (Lamiaceae); 2.12 Petiveria alliacea L.; 2.13 Salvia guaranitica St. Hil. (Lamiaceae); 2.14 Sceletium tortuosum (L.) N.E. Brown (Aizoaceae); 2.15 Sorbus alnifolia (Sieb. et Zucc.) K. Koch (Rosaceae); 2.16 Stereospermum kunthianum Cham. (Bignoniaceae); 2.17 Tilia tomentosa Moench (Tiliaceae); 2.18 Verbena officinalis L. (Verbenaceae); References
3: Neuropharmacology of Genus Hypericum: Hypericin and Hyperforin3.1 Hypericum perforatum Linn. (Guttiferae); 3.2 Habitat; 3.3 Botany; 3.4 Traditional Use in Treatment of Diseases of the Nervous System; 3.5 Chemistry; 3.5.1 Napthodianthrones; 3.5.2 Acylphloroglucinols; 3.5.3 Flavonoids; 3.5.4 Flavanols; 3.5.5 Xanthones and Sterols (Mathis and Ourisson 1964); 3.5.6 Terpenoids; 3.6 Neuropharmacology of H. perforatum Extract; 3.6.1 Non-clinical Studies; 3.6.1.1 Antidepressant Activity; 3.6.1.2 Anxiolytic Activity; 3.6.1.3 Anti-dementia Activity; 3.6.1.4 Antistress Activity
3.6.1.5 Neuroprotective Activity3.7 Neuropharmacology of Hypericin; 3.7.1 Non-clinical; 3.7.2 Clinical; 3.8 Neuropharmacology of Pseudohypericin; 3.9 Neuropharmacology of H. perforatum Xanthones; 3.10 Neuropharmacology of H. perforatum Flavonoids; 3.11 Neuropharmacology of Hyperforin; 3.11.1 Non-clinical; 3.11.2 Clinical; 3.12 Neuropharmacology of Adhyperforin; 3.13 Clinical Pharmacology of H. perforatum Extract; 3.13.1 Clinical Trials in Depression; 3.13.1.1 Mild to Moderate Depression; 3.13.1.2 Severe Major Depression; 3.13.2 Hypericum and Seasonal Affective Disorder (SAD)
3.13.3 Hypericum and Obsessive-Compulsive Disorder (OCD)3.13.4 Comparative Trials with Synthetic Drugs; 3.13.4.1 Hypericum Extract vs Maprotiline; 3.13.4.2 Hypericum Extract Versus Imipramine; 3.13.4.3 Hypericum Extract Versus Amitriptyline; 3.13.4.4 Hypericum Extract Versus Fluoxetine; 3.13.4.5 Hypericum Extract Versus Sertraline; 3.13.4.6 Hypericum Extract Versus Citalopram; 3.13.4.7 Hypericum Extract Versus Paroxetine; 3.14 Neuropharmacology of Other Hypericum Species; 3.14.1 Hypericum calycinum L.; 3.14.2 Hypericum caprifoliatum Cham. & Schltdl.
2.7 Litsea glaucescens Kunth (Lauraceae)2.8 Leonurus sibiricus L. (Lamiaceae); 2.9 Melissa officinalis L. (Lamiaceae); 2.10 Nepeta cataria L. (Lamiaceae); 2.11 Nepeta hindostana (Roth) Haines (Lamiaceae); 2.12 Petiveria alliacea L.; 2.13 Salvia guaranitica St. Hil. (Lamiaceae); 2.14 Sceletium tortuosum (L.) N.E. Brown (Aizoaceae); 2.15 Sorbus alnifolia (Sieb. et Zucc.) K. Koch (Rosaceae); 2.16 Stereospermum kunthianum Cham. (Bignoniaceae); 2.17 Tilia tomentosa Moench (Tiliaceae); 2.18 Verbena officinalis L. (Verbenaceae); References
3: Neuropharmacology of Genus Hypericum: Hypericin and Hyperforin3.1 Hypericum perforatum Linn. (Guttiferae); 3.2 Habitat; 3.3 Botany; 3.4 Traditional Use in Treatment of Diseases of the Nervous System; 3.5 Chemistry; 3.5.1 Napthodianthrones; 3.5.2 Acylphloroglucinols; 3.5.3 Flavonoids; 3.5.4 Flavanols; 3.5.5 Xanthones and Sterols (Mathis and Ourisson 1964); 3.5.6 Terpenoids; 3.6 Neuropharmacology of H. perforatum Extract; 3.6.1 Non-clinical Studies; 3.6.1.1 Antidepressant Activity; 3.6.1.2 Anxiolytic Activity; 3.6.1.3 Anti-dementia Activity; 3.6.1.4 Antistress Activity
3.6.1.5 Neuroprotective Activity3.7 Neuropharmacology of Hypericin; 3.7.1 Non-clinical; 3.7.2 Clinical; 3.8 Neuropharmacology of Pseudohypericin; 3.9 Neuropharmacology of H. perforatum Xanthones; 3.10 Neuropharmacology of H. perforatum Flavonoids; 3.11 Neuropharmacology of Hyperforin; 3.11.1 Non-clinical; 3.11.2 Clinical; 3.12 Neuropharmacology of Adhyperforin; 3.13 Clinical Pharmacology of H. perforatum Extract; 3.13.1 Clinical Trials in Depression; 3.13.1.1 Mild to Moderate Depression; 3.13.1.2 Severe Major Depression; 3.13.2 Hypericum and Seasonal Affective Disorder (SAD)
3.13.3 Hypericum and Obsessive-Compulsive Disorder (OCD)3.13.4 Comparative Trials with Synthetic Drugs; 3.13.4.1 Hypericum Extract vs Maprotiline; 3.13.4.2 Hypericum Extract Versus Imipramine; 3.13.4.3 Hypericum Extract Versus Amitriptyline; 3.13.4.4 Hypericum Extract Versus Fluoxetine; 3.13.4.5 Hypericum Extract Versus Sertraline; 3.13.4.6 Hypericum Extract Versus Citalopram; 3.13.4.7 Hypericum Extract Versus Paroxetine; 3.14 Neuropharmacology of Other Hypericum Species; 3.14.1 Hypericum calycinum L.; 3.14.2 Hypericum caprifoliatum Cham. & Schltdl.